Cargando…
Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies
SIMPLE SUMMARY: Glioma is the most common primary intracranial tumor.Glioma involves a wide variety of cells and is highly aggressive, so most patients with glioblastoma have a poor prognosis.Glioma involves a wide variety of cells and is highly aggressive, so most patients with glioblastoma have a...
Autores principales: | Kang, Xianhui, Wang, Yijian, Liu, Pan, Huang, Baojun, Zhou, Baofeng, Lu, Shufang, Geng, Wujun, Tang, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856991/ https://www.ncbi.nlm.nih.gov/pubmed/36672345 http://dx.doi.org/10.3390/cancers15020396 |
Ejemplares similares
-
Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018) -
Challenges Facing CRISPR/Cas9-Based Genome Editing in Plants
por: Son, Seungmin, et al.
Publicado: (2022) -
CRISPR/Cas9 therapeutics: progress and prospects
por: Li, Tianxiang, et al.
Publicado: (2023) -
Application of CRISPR/Cas9 Genome Editing Technology for the Improvement of Crops Cultivated in Tropical Climates: Recent Progress, Prospects, and Challenges
por: Haque, Effi, et al.
Publicado: (2018) -
CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)